Prof Sandi Hayes recognised by ESSA for International Women’s Day
Congratulations to QUT Improving Health Outcomes for People leader Professor Sandi Hayes who was selected this year by ESSA (Exercise and Sports Science Australia) as a pioneering women in the exercise and sports science industry.
This year’s International Women’s Day campaign looked at #BeBoldForChange, and last month ESSA called for nominations for influential women who have actively worked for change in this industry. Prof Hayes was one of three women selected by a panel for portraying true leadership and influential change.
Fundraiser for Cherish
QUT Improving Health Outcomes for People is a proud support of the Cherish Women’s Cancer Foundation. Cherish funds clinical research that results in better treatments for gynaecological cancer patients.
Cherish is hosting its annual Battle. The Battle is a beach volleyball tournament aiming to raise money for much needed research into gynaecological cancer. The Battle will be held in Brisbane on Friday 17th March 2017.
The Imagine Trial has commenced
The Imagine trial aims to implement and evaluate an innovative training and mentoring program for surgeons who perform laparoscopic (keyhole) hysterectomy.
The first stage of the Imagine trial commenced last week at the Train-the-Trainers workshop.
Happy Holidays! Don’t forget to block the blaze this summer
Have a safe and happy holidays from the ihop research team. Remember to stay sun safe this summer and block the blaze using these 5 easy tips.
The Implementation of Minimally Invasive Hysterectomy: The Imagine trial
The Imagine trial aims to implement and evaluate an innovative training and mentoring program for surgeons who perform laparoscopic (keyhole) hysterectomy. Hysterectomy is the surgical procedure to remove the uterus.
Hysterectomy is the most commonly performed major gynaecological procedure in women. Approximately 30,000 hysterectomies are performed in Australia each year. Hysterectomy can be performed for a number of reasons such as uterine fibroids, pelvic masses, endometriosis/adenomyosis and cancer.
World Cancer Research Fund grant: The ECHO trial
Prof Sandi Hayes, is excited to announce ihop’s current ECHO trial has received funding from the World Cancer Research Fund (WCRF) International for further expansion. The ECHO trial evaluates the effects of an exercise intervention during first-line chemotherapy for ovarian cancer.
Ovarian cancer is the most common cause of gynaecological cancer death, with an overall 5-year relative survival of only 43%. Treatment for ovarian cancer typically involves extensive surgery and high-dose chemotherapy with adverse side effects impacting physical wellbeing, function and quality of life.
Seeking participants for a research study about UV SPOTS for sunscreen use
QUT Improving Health Outcomes for People researcher Dr Elke Hacker is conducting a project on UV devices and their effectiveness on sun protective behaviour. These include UV SPOTS and personalised wearable weather stations.
What’s involved?
Attending the world congress of cancers of the skin
QUT Improving Health Outcomes for People co-leader Prof Monika Janda recently attended the 16th World Congress on Cancers of the Skin in Vienna, Austria.
The world congress of cancers of the skin holds interdisciplinary meetings for clinicians and scientists working in the challenging fields of melanoma and non-melanoma skin cancer.
Mobile technologies improve skin cancer prevention outcomes
Mobile phone-delivered technologies can improve skin cancer prevention outcomes, according to a QUT Improving Health Outcomes for People research group study.
Linda Finch, group manager and research officer from the research group at Queensland University of Technology, published her findings in the renowned international journal Preventive Medicine.
Gynaecological cancer fundraiser – The Battle
QUT Improving Health Outcomes for People research group is a proud support of the Cherish Women’s Cancer Foundation. Cherish Women’s Cancer Foundation’s goal is to find and fund clinical research that results in better treatments for gynaecological cancer patients.
Approximately 5000 women are diagnosed with gynaecological cancer each year in Australia, and a third of these will not survive.
